![Evolent Health's SWOT analysis: stock faces challenges amid growth potential](https://i-invdn-com.investing.com/news/World_News_9_150x108_S_1420026261.jpg)
Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 100.000 | 100.000 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 10.489 | 15.249 |
Price to Book | 1.289 | 2.118 |
Price to Sales | 0.871 | 1.576 |
Price to Cash Flow | 4.088 | 8.730 |
Dividend Yield | 1.785 | 2.578 |
5 Years Earnings Growth | 13.442 | 12.267 |
Number of long holdings: 1
Number of short holdings: 0
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
azValor Internacional FI | ES0112611001 | 0.00 | 241.459 | -0.57% | |
Cartesio X FI | ES0116567035 | 0.00 | 2,320.20 | +0.15% | |
Cobas Internacional FI | ES0119199000 | 0.00 | 134.921 | +0.19% | |
Magallanes Microcaps Europe B FI | ES0159202011 | 0.00 | 149.729 | +0.29% | |
Magallanes European Equity P FI | ES0159259029 | 0.00 | 235.187 | -0.26% | |
True Value FI | ES0180792006 | 0.00 | 21.16 | +0.75% | |
Markel Corp | - | 0.00 | - | - | |
Sextant PEA A | FR0010286005 | 0.00 | 1,041.800 | +0.45% | |
Berkshire Hathaway Inc Class B | - | 0.00 | - | - | |
Sextant Bond Picking N | FR0013202140 | 0.00 | 5,839.010 | +0.15% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
GESPRISA INVERSIONES SICAV SA | 1.6B | 4.25 | 16.83 | 12.69 | ||
Gunton De Invesriones | 158.98M | 1.54 | 5.02 | 4.48 | ||
CURRELOS DE INVERSIONES SICAV SA | 85.32M | 2.01 | 4.80 | 3.98 | ||
INVERSIONESNANCIERAS JUPEDAL | 77.6M | 2.09 | 3.98 | 2.02 | ||
PROFUNDIZA INVESTMENT | 76.72M | 1.96 | 2.83 | 2.63 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review